{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:06:30Z","timestamp":1790687190161,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.trecan.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T07:28:30Z","timestamp":1586590110000},"page":"540-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Epigenetic Biomarkers in Gallbladder Cancer"],"prefix":"10.1016","volume":"6","author":[{"given":"Pramod K.","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2020.03.003_bb0005","series-title":"eLS","first-page":"1","article-title":"Molecular genetics of gallbladder cancer","author":"Espinoza","year":"2015"},{"key":"10.1016\/j.trecan.2020.03.003_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2020.03.003_bb0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/ajco.12507","article-title":"Epigenetic regulation in gallbladder cancer: promoter methylation profiling as emergent novel biomarkers","volume":"12","author":"Tekcham","year":"2016","journal-title":"Asia Pac. J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2020.03.003_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.gendis.2018.06.003","article-title":"Epigenetic mechanisms as a new approach in cancer treatment: an updated review","volume":"5","author":"Fardi","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.trecan.2020.03.003_bb0025","doi-asserted-by":"crossref","first-page":"14687","DOI":"10.1007\/s13277-016-5355-9","article-title":"Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease","volume":"37","author":"Sharma","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.trecan.2020.03.003_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-018-0492-1","article-title":"Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage","volume":"10","author":"Wang","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.trecan.2020.03.003_bb0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fonc.2019.00669","article-title":"Crosstalk between long non-coding RNAs, micro-RNAs and mRNAs: deciphering molecular mechanisms of master regulators in cancer","volume":"9","author":"L\u00f3pez-Urrutia","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2020.03.003_bb0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic targeting of long non-coding RNAs in cancer","volume":"24","author":"Arun","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.trecan.2020.03.003_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.gene.2016.04.047","article-title":"Non-coding RNAs as emerging molecular targets in gallbladder cancer","volume":"588","author":"Tekcham","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.trecan.2020.03.003_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3892\/mco.2016.905","article-title":"The role of microRNAs in gallbladder cancer (review)","volume":"5","author":"Yang","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.trecan.2020.03.003_bb0055","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1007\/s13277-015-3412-4","article-title":"MicroRNA signatures in total peripheral blood of gallbladder cancer patients","volume":"36","author":"Li","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.trecan.2020.03.003_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41591-019-0376-8","article-title":"Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer","volume":"25","author":"Mohammad","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2020.03.003_bb0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rajesha","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.trecan.2020.03.003_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2019.08.017","article-title":"Sex disparities in cancer","volume":"466","author":"Zhua","year":"2019","journal-title":"Canc. Lett."},{"key":"10.1016\/j.trecan.2020.03.003_bb0070","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5114\/ceh.2019.85166","article-title":"Epidemiology of gallbladder cancer","volume":"5","author":"Prashanth","year":"2019","journal-title":"Clin. Exp. Hepatol."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803320301047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803320301047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:51:40Z","timestamp":1762505500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803320301047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2405803320301047"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2020.03.003","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic Biomarkers in Gallbladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}